Elevated IL-10 in diabetes causes capillary obstruction, linked to cognitive deficits. Blocking IL-10 receptors shows promise for improving brain function.
Pfizer lands FDA approval for $6.7B ulcerative colitis drug, taking on antibodies as an oral alternative
Pfizer has secured an FDA approval for etrasimod in moderate to severe ulcerative colitis. It’s the second sphingosine-1-phosphate (S1P) drug to arrive on the UC